Layout:
You are viewing: Main Page

(TISI, REXI, GBCI, GBLHF, STFC) Featured Stock by Stock-PR.com

January 4th, 2012 at 02:47 pm

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com











Team, Inc., (NYSE:TISI) reported second quarter net income available to common shareholders of $10.3 million ($0.50 per diluted share), an increase of $2.3 million, or 28%, compared to the second quarter of last year. Revenues for the second quarter were $158.3 million, an increase of $25.1 million, or 19%, compared to the second quarter of last year.

Highlights

Second quarter revenues of $158.3 million, including $10 million from Quest Integrity Group.

Quarterly revenue growth of 19%; organic revenue growth of 13%.

Double digit revenue growth in all major geographic regions -- US, Canada, and Europe.

Adjusted EBIT margin of 11.3% for the quarter.

Adjusted net income of $10.8 million ($0.53 per diluted share) for the quarter, up 28%.

Expansion of Team capabilities via two small acquisitions:

1. A pipeline integrity management firm within the TCM group, and

2. The west coast operations of a former TMS competitor (completed December 30, 2011).

NYSE listing effective January 3, 2012 (same "TISI" ticker symbol).


Headquartered in Alvin, Texas, Team, Inc. is a leading provider of specialty services required in managing, maintaining and installing high-temperature and high-pressure piping systems and vessels that are utilized extensively in the refining, petrochemical, power, pipeline and other heavy industries. Team offers these services in over 100 locations throughout the world.

More about TISI at www.teamindustrialservices.com.

Read the full article at: http://stock-pr.com/21117/stock-alerts/tisi-rexi-gbci-gblhf-stfc-featured-stock-by-stock-prcom/

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Sign Up For Free Stock Alerts At http://stock-pr.com/signup


(PFE, CRWE, WSM, PKO, ANH) Featured Stock by Stock-PR.com

December 31st, 2011 at 04:38 pm

Stock-PR Reporting







FREE Daily Stock Alerts From Stock-PR.com








Pfizer, Inc. (NYSE:PFE)

PFE recently reported that the U.S. Food and Drug Administration (FDA) has granted approval of the Company’s pneumococcal conjugate vaccine Prevnar 13®* (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) as a single dose for use in adults. Prevnar 13 is indicated for adults 50 years of age and older for active immunization for the prevention of pneumonia and invasive disease caused by the 13 Streptococcus pneumoniae (S. pneumoniae) serotypes contained in the vaccine.

Prevnar 13 uses Company-pioneered conjugate technology that links pneumococcal polysaccharide sugar chains found on the surface of each bacterial serotype with a carrier protein. Prevnar 13 uses the carrier protein CRM197, which has more than 20 years of clinical and commercial use in vaccines.

At PFE, they apply science and their global resources to improve health and well-being at every stage of life. They strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Their diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world’s best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with their responsibility as the world’s leading biopharmaceutical company, they also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on them.


For more information about PFE please visit http://www.pfizer.com



Read the full article at: http://stock-pr.com/21103/stock-alerts/pfe-crwe-wsm-pko-anh-featured-stock-by-stock-prcom/

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Sign Up For Free Stock Alerts At http://stock-pr.com/signup


(STAN, CRWE, NGD, LSG, CBP) Featured Stock by Stock-PR.com

December 30th, 2011 at 02:52 pm

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com









Standard Parking, SP Plus(R) Announce Medical Center Contract Awards



Standard Parking Corporation (Nasdaq:STAN) one of the nation's leading providers of parking management, ground transportation and other ancillary services, announced contract awards from two prominent medical center clients. The Mount Sinai Hospital and Medical Center in New York selected SP Plus Transportation to provide shuttle bus services under a multi-year contract. The Athens Regional Medical Center, a premier healthcare provider in Athens, Ga., selected SP Plus Healthcare Services to provide parking services for two parking garages and one surface lot.

The Mount Sinai Hospital and Medical Center, one of the nation's largest, oldest and most respected hospitals, selected SP Plus Transportation to provide shuttle bus services for The Mount Sinai Hospital, The Mount Sinai School of Medicine and The Mount Sinai Hospital of Queens. The service, which started October 1st, operates buses on five separate routes transporting employees, medical residents and patients. Standard Parking's SP Plus Healthcare services operating division has been managing the Medical Center's parking operation since being awarded that contract in January 2011.

Under SP Plus Healthcare Services' agreement with the Athens Regional Medical Center, the Company will oversee the management and maintenance of 2,100 parking spaces. As part of its duties, SP Plus Healthcare Services will hire and train cashiers as well as provide ambassadorial services for Medical Center staff and patients.

Standard Parking is a leading national provider of parking facility management, ground transportation and other ancillary services. The Company, with approximately 12,000 employees, manages approximately 2,100 facilities, containing over one million parking spaces in hundreds of cities across North America, including parking-related and shuttle bus operations serving more than 60 airports.

More about STAN at www.standardparking.com



Read the full article at: http://stock-pr.com/21089/stock-alerts/stan-crwe-ngd-lsg-cbp-featured-stock-by-stock-prcom/

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Sign Up For Free Stock Alerts At http://stock-pr.com/signup


(ORBC, DLPH, OFC, GBLHF, SWY) Featured Stock by Stock-PR.com

December 29th, 2011 at 02:51 pm

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com









ORBCOMM and SpaceX Improve Launch Plans for OG2 Satellites

- Enhanced Worldwide Coverage with an Additional Polar Launch of Two OG2 Satellites -




ORBCOMM Inc. (Nasdaq: ORBC) and Space Exploration Technologies (SpaceX) announced the launch schedule for ORBCOMM’s second generation (OG2) satellites. The updated plan includes launching the first OG2 prototype satellite on the first Cargo Re-supply Services (CRS) mission in mid-2012, followed closely by an additional launch of two OG2 satellites into a high inclination orbit as a secondary payload in late 2012. In early 2013, SpaceX plans to launch eight to twelve OG2 satellites, and the remainder of the constellation of 18 OG2 satellites is expected to be launched in 2014. All launches are expected to be on Falcon 9 rockets.

In transitioning the launch of the first OG2 prototype spacecraft to the first CRS mission in lieu of the upcoming Commercial Orbital Transportation Services (COTS) mission, and adding the launch of two spacecraft toward the second half of 2012, ORBCOMM is able to field additional spacecraft in 2012 resulting in increased coverage, while spreading the deployment across multiple launches thereby reducing risk. SpaceX will fully verify the mission performance on the COTS mission and focus on the successful berthing of the Dragon spacecraft to the International Space Station (ISS).

“We are pleased that SpaceX has offered ORBCOMM this opportunity to launch two satellites that will help our customers using our OG2 messaging services, and additionally augment service to our maritime Automatic Identification System (AIS) customers that benefit from coverage at higher inclinations,” said Marc Eisenberg CEO of ORBCOMM. “The net outcome of these revised launch plans has us launching OG2 satellites at a faster pace with less risk.”

The parameters of the Falcon 9 launch of eight to twelve OG2 satellites as its primary mission in early 2013 will be optimized to ensure the best coverage for the enhanced OG2 messaging services. ORBCOMM expects several OG2 satellites will be directly inserted into a specific plane to immediately improve messaging services while other satellites will be put into a transfer orbit and drift to their final orbit location. ORBCOMM expects the drifting operation will take several months to occur and that the satellites will be functional and providing messaging services during this period.

ORBCOMM is a leading global satellite data communications company, focused on Machine-to-Machine (M2M) communications. Its customers include Caterpillar Inc., Doosan Infracore America, Hitachi Construction Machinery, Hyundai Heavy Industries, Asset Intelligence (a division of I.D. Systems, Inc.), Komatsu Ltd., Manitowoc Crane Companies, Inc., and Volvo Construction Equipment among other industry leaders. By means of a global network of low-earth orbit (LEO) satellites and accompanying ground infrastructure, ORBCOMM’s low-cost and reliable two-way data communication services track, monitor and control mobile and fixed assets in four core markets: commercial transportation; heavy equipment; industrial fixed assets; and marine/homeland security.



More about ORBC at www.orbcomm.com.

Read the full article at: http://stock-pr.com/21079/stock-alerts/orbc-dlph-ofc-gblhf-swy-featured-stock-by-stock-prcom/

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Sign Up For Free Stock Alerts At http://stock-pr.com/signup


(NSPH, VCBI, CLNO, FRBK, PBHC) Featured Stock by Stock-PR.com

December 28th, 2011 at 02:44 pm

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com











Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that it has received 510(k) clearance from the FDA for the Verigene(R) Staphylococcus Blood Culture Nucleic Acid Test (BC-S). The BC-S test expands Nanosphere's infectious disease test capabilities to include the rapid detection of bacteria that cause deadly bloodstream infections.

The Verigene BC-S test was submitted to the FDA as the first phase of a stepwise process to obtain clearance for a larger test panel which will be marketed as the Verigene BC-GP test. The test will be comprised of up to 16 bacterial/resistance marker targets, all on a single test cartridge. A second 510(k), needed to obtain clearance for the full BC-GP test panel, is currently under FDA review. Last week, Nanosphere obtained CE-IVD Mark for regulatory approval of the full BC-GP test as an in vitro diagnostic in Europe.

"With the BC-S test, clinicians diagnosing patients suspected of deadly infections have a rapid, accurate molecular diagnostic tool which can differentiate two important disease-causing Staphylococcus bacteria, while simultaneously determining antibiotic resistance within the critical timeframe for making and adjusting initial treatment decisions," said Nanosphere CEO Bill Moffitt. "With this clearance we continue expansion of our product offering, enabling microbiologists to replace century-old methods with rapid, accurate molecular diagnostic tests," he added.

In a single automated test, the Verigene BC-S test provides detection of Staphylococcus aureus, Staphylococcus epidermidis, and the mecA gene. The mecA gene confers resistance to the antibiotic methicillin/oxacillin. Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is associated with a significantly higher mortality rate than methicillin-susceptible Staphylococcus aureus bacteremia, posing a substantial healthcare burden.

Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene System, for multiplexed infectious disease, genetic, and ultra-sensitive protein testing. This easy-to-use platform offers laboratories a convenient, simple, and cost-effective solution for highly sensitive nucleic acid and protein testing. Nanosphere is based in Northbrook, IL.

More about NSPH at www.nanosphere.us.



Read the full article at: http://stock-pr.com/?p=21068

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services and 4,000,000 shares of 144 restricted stocks from the company for management fee through end of June for Cleantech Transit, Inc. (CLNO.OB).

Sign Up For Free Stock Alerts At http://stock-pr.com/signup


(HWCC, CRWE, WWAY, BBBY) Featured Stock by Stock-PR.com

December 26th, 2011 at 10:30 am

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com







Houston Wire & Cable Company (NASDAQ:HWCC) announced that, in accordance with its previously announced succession plan, the Board of Directors has named James L. Pokluda III, President of the Company, to the additional position of Chief Executive Officer and elected Mr. Pokluda to the Company's Board, effective January 1, 2012. Mr. Pokluda will replace Charles A. Sorrentino, the Company's current CEO, who as previously reported, will resign from the Board and retire as Chief Executive Officer at year end.

Read full article at: http://stock-pr.com/?p=21056




THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer). Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

(NAUH, CLNO, RENT, TESS) Stock Report from Stock-PR.com

December 26th, 2011 at 10:23 am

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com







National American University Holdings, Inc. (NASDAQ:NAUH), which through its wholly owned subsidiary operates National American University, a regionally accredited, proprietary, multi-campus institution of higher learning, announced that it will release financial results for its fiscal 2012 second quarter and six months ended November 30, 2011, after the closing of the stock market on Wednesday, January 4, 2012. The Company will then discuss those results in a conference call on Thursday, January 5, 2012, at 11:00 a.m. ET.

Read full article at: http://stock-pr.com/?p=21055



THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer). Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services and 4,000,000 shares of 144 restricted stocks from the company for management fee through end of June for Cleantech Transit, Inc. (CLNO.OB).

(EBAY, HSNI, MJGCF, VMED) Stock Updates by Stock-PR.com

December 26th, 2011 at 10:19 am

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com







eBay Inc. (Nasdaq:EBAY) announced that it has acquired BillSAFE, a leading provider of purchase-on-invoice technology in Germany. The acquisition extends the company's leadership in payments by combining BILLSAFE with eBay's PayPal, a global leader in online payments. The deal follows eBay Inc.'s minority stake investment in the company in October 2010. eBay Inc. now owns 100 percent of the outstanding shares of BillSAFE. Terms of the deal were not disclosed.

Read full article at: http://stock-pr.com/?p=21054



THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer). Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

(PARL, MGN, HBP, MJGCF, CXM) Featured Stock by Stock-PR.com

December 24th, 2011 at 04:07 pm

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com








Parlux Fragrances Inc. (NASDAQ:PARL)

Perfumania Holdings, Inc. and PARL previously announced that they have signed a definitive merger agreement under which Perfumania would acquire all of the outstanding shares of Parlux in a transaction valued at approximately $170 million, based on Perfumania's closing stock price of $19.55 per share on December 22, 2011. Based on that Perfumania stock price and depending on the stockholder elections described below, the merger agreement values a share of Parlux stock at between $7.91 and $8.55, assuming no adjustments under the merger agreement other than such elections. Parlux's closing market price on December 22, 2011 was $3.40 per share, and there were 20,769,362 shares of Parlux common stock outstanding on that date. Parlux stockholders will be entitled to elect between mixed stock and cash consideration and principally stock consideration under the merger agreement. The actual value of the per-share merger consideration payable to a stockholder will vary based upon the market price of Perfumania's stock when the merger closes, as well as the stockholders' elections and adjustments provided for in the merger agreement.

"The Parlux management team and Board of Directors are focused on maximizing value for stockholders. This combination achieves that objective by providing our shareholders with a significant premium over the current trading price for their shares as well as the ability to participate in the anticipated growth of a significantly stronger, combined company that is well positioned to deliver long-term value to stockholders and a broader range of product to its valued customers," stated Parlux's Chairman and Chief Executive Officer Fred Purches.

PARL is a manufacturer and international distributor of prestige fragrances and beauty related products. It holds licenses and sublicenses to manufacture and distribute the designer fragrance brands of Paris Hilton, Jessica Simpson, Nicole Miller, Josie Natori, Queen Latifah, Marc Ecko, Rihanna, Kanye West, Vince Camuto and Fred Hayman Beverly Hills.

For more info about PARL visit http://www.parlux.com



Read the full article at: http://stock-pr.com/?p=21049

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Sign Up For Free Stock Alerts At http://stock-pr.com/signup


(AIS, CLNO, NTN, URZ) Stock Updates by Stock-PR.com

December 24th, 2011 at 11:22 am

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com







Antares Pharma, Inc. (Amex:AIS) announced that it has licensed to Pfizer Inc.'s Consumer Healthcare Business Unit one of its drug delivery technologies to develop an undisclosed product on an exclusive basis for North America. Pfizer will assume full cost and responsibility for all clinical development, manufacturing, and commercialization of the product in the licensed territory, which also includes certain non-exclusive territories outside of North America. Antares will receive undisclosed upfront payments, development milestones and sales based milestones, as well as royalties on net sales for three years post launch in the US.

Read full article at: http://stock-pr.com/?p=21043



THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer). Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services and 4,000,000 shares of 144 restricted stocks from the company for management fee through end of June for Cleantech Transit, Inc. (CLNO.OB).

(MNTA, CSKI, XOMA, CLNO, MSHL) Stock in Review by CRWEPicks.Com

December 23rd, 2011 at 03:31 pm









Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) is applying its technology to the development of generic versions of complex drug products, as well as to the discovery and development of novel drugs. Momenta Pharmaceuticals was founded in 2001 and is a biotechnology company specializing in the detailed structural analysis of complex drugs headquartered in Cambridge, Mass.



Baxter International Inc. and Momenta Pharmaceuticals yesterday announced that they have entered into a global collaboration to develop and commercialize follow-on biologic products, also known as biosimilars. Biosimilars replicate existing, branded biologics used in the treatment of a variety of diseases including cancer, autoimmune disorders and other chronic conditions. With this collaboration, Baxter will leverage its leading clinical development and biologic manufacturing expertise, global leadership in sterile injectables and global commercial capabilities, while Momenta will provide its expertise in high-resolution analytics, characterization, and product and process development.

Read full article at : http://crwepicks.com/19347/top-news/mnta-cski-xoma-clno-mshl-stock-in-review-by-crwepickscom/


THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The CRWEPicks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer (http://crwepicks.com/disclaimer ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEPicks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. ( read more at http://crwepicks.com/disclaimer ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings, Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings, Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings, Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings, Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services and 4,000,000 shares of 144 restricted stocks from the company for management fee through end of June for Cleantech Transit, Inc. (CLNO.OB).

(MNTA, TAYC, KRNY, CLNO, FULT) Stock Updates by Stock-PR.com

December 23rd, 2011 at 02:44 pm

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com











Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) and Baxter International Inc. announced that they have entered into a global collaboration to develop and commercialize follow-on biologic products, also known as biosimilars. Biosimilars replicate existing, branded biologics used in the treatment of a variety of diseases including cancer, autoimmune disorders and other chronic conditions. With this collaboration, Baxter will leverage its leading clinical development and biologic manufacturing expertise, global leadership in sterile injectables and global commercial capabilities, while Momenta will provide its expertise in high-resolution analytics, characterization, and product and process development.

Under the terms of the agreement, Baxter will make an upfront cash payment of $33 million to Momenta related to the collaboration for up to six follow-on biologic compounds. Baxter may make additional payments over the next several years for the development of the compounds, contingent upon the achievement of technical, development and regulatory milestones with respect to all six products.

Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex mixture drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drug products, as well as to the discovery and development of novel drugs. To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.



Read the full article at: http://stock-pr.com/?p=21035

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services and 4,000,000 shares of 144 restricted stocks from the company for management fee through end of June for Cleantech Transit, Inc. (CLNO.OB).

(ASBC, PBCT, MJGCF, VPFG) Stock Highlights by Stock-PR.com

December 23rd, 2011 at 11:16 am

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com







Associated Banc-Corp (Nasdaq:ASBC) announced it will release 2011 fourth quarter results on Thursday, January 19, 2012 after market close. The company will host a conference call for investors and analysts at 4:00 p.m. Central Time (CT) on the same day.


Read full article at: http://stock-pr.com/?p=21034



THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

*****************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

(CRWE, CVBF, ROMA, FMBI) Stock Report from Stock-PR.com

December 23rd, 2011 at 11:09 am

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com







Crown Equity Holdings Inc., (CRWE)

Videos are easier to produce than articles for most people. Most business owners and people in general hesitate when asked to write an article, but can readily agree to hold a camera and shoot a video. With the advent of smart phone cameras and easy to use digital cameras, just about anyone can shoot a video making it a simple, quick and cheap option to any business owner.

Read full article at: http://stock-pr.com/?p=21033





THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer). Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

(FC, PACD, MPR, CLNO) Stock Report from Stock-PR.com

December 22nd, 2011 at 10:47 am

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com







Franklin Covey Co. (NYSE:FC) announced that 20 plus Navodaya Vidyalaya Samiti (NVS) Schools in India are piloting Franklin Covey's flagship training, The 7 Habits of Highly Effective People, which is being fully funded by the Government of India.

Read full article at: http://stock-pr.com/?p=21023

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

*****************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services and 4,000,000 shares of 144 restricted stocks from the company for management fee through end of June for Cleantech Transit, Inc. (CLNO.OB).

(FXCM, MJGCF, TTI, TMS) Stock Updates by Stock-PR.com

December 22nd, 2011 at 10:42 am

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com







FXCM Inc. (NYSE:FXCM), a leading online provider of foreign exchange, or FX, trading and related services, announced that FXCM Holdings LLC has entered into a three year revolving credit facility with Bank of America, N.A., as Administrative Agent and several lenders from time to time parties thereto. The credit agreement provides for a $75 million revolving credit facility that may be increased during its three year term by up to $75 million for a total of up to $150 million.

Read full article at: http://stock-pr.com/?p=21022



THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer). Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

(COMV, COVR, MJGCF, NGD, MFN) Featured Stock by Stock-PR.com

December 21st, 2011 at 03:30 pm

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com











Comverge, Inc. (Nasdaq:COMV), the leading provider of Intelligent Energy Management solutions for Residential and Commercial & Industrial (C&I) customers, announced that it has been selected by Eskom, the largest electricity provider in Africa, to manage its complex supply and demand challenges by creating and co-managing Africa's first open market for demand response resources. Under the terms of the approximately $27 million agreement, Comverge will deploy the IntelliSOURCE 2.0 platform for Eskom to register, dispatch and operate a new competitive demand response market in South Africa for an initial 500 Megawatts (MWs) of demand response resources. In addition, the agreement calls for Comverge to provide at least 100 MWs directly as one of the new curtailment service providers (CSPs) serving this newly established market.

Additional Details on the South African Demand Response Deployment

This is the first client win since Comverge established its new International subsidiary in March 2011 and represents the nineteenth deployment of Comverge's IntelliSOURCE platform.

The Comverge IntelliSOURCE 2.0 platform is the industry's most advanced, enterprise-class software platform and operating environment that incorporates the insight and control needed to realize the value from a true two-way dialogue between energy providers and consumers.

This new competitive market for demand response resources will help optimize energy usage in South Africa by creating and fostering new demand response companies within the country.

The scalability and flexibility of the Comverge IntelliSOURCE 2.0 platform across multiple customer classes will allow Eskom to accurately evaluate the potential for commercial, industrial and residential demand response programs in the country.

The terms of the contract are for a pilot program scheduled to run through March 31, 2013.

To support the partnership with Eskom, Comverge will open a new office in Johannesburg, South Africa.

With more than 500 utility and 2,100 commercial customers, as well as five million deployed residential devices, Comverge brings unparalleled industry knowledge and experience to offer the most reliable, easy-to-use, and cost-effective intelligent energy management programs. We deliver the insight and control that enables energy providers and consumers to optimize their power usage through the industry's only proven, comprehensive set of technology, services and information management solutions.

More about COMV at www.comverge.com



Read the full article at: http://stock-pr.com/?p=21016

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

(GST, CRWE, FPP, GMO) Stock Report from Stock-PR.com

December 21st, 2011 at 09:36 am

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com







Gastar Exploration Ltd. (Amex:GST) provided an operational update on recent activities in Marshall County, West Virginia within the Marcellus shale area. Gastar's first two productive Marcellus shale wells, the Wengerd 1H and Wengerd 7H, continue to exhibit strong production rates and have averaged a combined gross sales rate of 7.3 million cubic feet per day ("MMCFD") of natural gas along with 448 barrels of natural gas liquids ("NGLs") per day and 255 barrels of condensate per day ("BCPD") over the most recent 14 days of unrestricted production. Gastar owns a 44.5% working interest (37.6% net revenue interest) in the Wengerd wells.

Read full article at: http://stock-pr.com/?p=21012





THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer). Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

(RIC, MVG, CLNO, AIS) Stock Updates by Stock-PR.com

December 21st, 2011 at 09:29 am

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com






Richmont Mines Inc. (Amex:RIC), announced resource estimates for its Monique project (the "Property"), located near Val-d'Or, Quebec. Highlights: Indicated open pit resources of 728,164 tonnes grading 2.35 g/t Au for 55,112 ounces of gold; Permit application for a small open pit operation on the Property submitted in November 2011; A 1,700 metre surface drilling program began in early December 2011.

Read ful article at: http://stock-pr.com/?p=21011



THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer). Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services and 4,000,000 shares of 144 restricted stocks from the company for management fee through end of June for Cleantech Transit, Inc. (CLNO.OB).

(UMH, RIC, LNG, MJGCF) Stocks in Focus by Stock-PR.com

December 19th, 2011 at 01:00 pm

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com













UMH Properties Inc. (Amex:UMH) announced that it will be presenting at Sidoti & Company's 2012 Semi-Annual Micro-Cap Conference on Monday, January 9 , 2012. The Forum will be held at The Grand Hyatt in New York City . Eugene W. Landy , Chairman of the Board, and Michael P. Landy , Executive Vice President, will present an overview on UMH followed by a question and answer session. The conference begins at 8:00 a.m. EST . UMH's presentation will be available at the company's website www.umh.com (from the homepage, select the Home tab, then Presentations and Documents) directly following the conference.



Read the full article at: http://stock-pr.com/?p=20992

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

APRI, CRWE, MET, WMB, M Stock Market Report from Stock.PR.com

December 19th, 2011 at 12:55 pm





FREE Daily Stock Alerts From Stock-PR.com









Apricus Biosciences Incorporated (Nasdaq:APRI) According to a a definitive agreement between the companies, Apricus Biosciences Incorporated will acquire Topotarget USA, who owns Totect (Dexrazoxane HCl), the only drug approved by the FDA to treat a potentially serious complication of cancer therapy—the leakage of chemotherapy drugs from veins into surrounding tissues.


This complication is known as anthracycline extravasation, and can lead to infections and tissue death.

With this acquisition, Apricus Biosciences will move into the commercialization and sales of oncology and oncology supportive care pharmaceuticals.

Apricus Biosciences is a revenue-generating, specialty pharmaceutical company, with commercial products and a broad pipeline across numerous therapeutic classes.

More about Apricus Biosciences Incorporated (Nasdaq:APRI) at www.apricusbio.com


Read the full article at: http://stock-pr.com/?p=20990

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**********************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer). Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

(CRWE, GPX, DTF, BEAM) Notable Stock by Stock-PR.com

December 17th, 2011 at 10:49 am

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com








Crown Equity Holdings Inc. (CRWE)

Crown Equity Holdings Inc., together with its digital network, currently provides electronic media services specializing in online publishing, which brings together targeted audiences and advertisers.

Read full article at: http://stock-pr.com/?p=20982






THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company.Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

(LOR, WDR, CLNO, EAT) Stock in Focus by Stock-PR.com

December 17th, 2011 at 10:43 am

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com









Lazard World Dividend & Income Fund Inc (NYSE:LOR) announced that its Board of Directors has authorized the Fund to declare, pursuant to a level distribution policy, a monthly distribution equal to, on an annualized basis, 6.5% of the Fund's net asset value per share as of the close of markets on December 31, 2011 on the Fund's outstanding common stock. The distribution is payable on January 23, 2012 to shareholders of record on January 12, 2012. The ex-dividend date is January 10, 2012.

Read full article at: http://stock-pr.com/?p=20981



THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company.Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services and 4,000,000 shares of 144 restricted stocks from the company for management fee through end of June for Cleantech Transit, Inc. (CLNO.OB)

(ZQK, RIMM, SWKS, CLNO, SREV) Stock Highlights by CRWEPicks.Com

December 16th, 2011 at 03:28 pm









The apparel and footwear brands from Quiksilver, Inc. (NYSE:ZQK) represent a casual lifestyle for young-minded people that connect with its boardriding culture and heritage. Quiksilver is the world’s leading outdoor sports lifestyle company, which designs, produces and distributes a diversified mix of branded apparel, footwear, accessories, snowboards and related products.



Quiksilver, Inc. (NYSE:ZQK) yesterday announced operating results for the fourth fiscal quarter and full year ended October 31, 2011. Revenues grew 10% to $545.2 million as compared to $495.1 million in the fourth quarter of fiscal 2010 and grew 6% in constant currency. Quiksilver earned Pro-forma Adjusted EBITDA of $57.1 million in the quarter compared to $59.5 million earned in the fourth quarter of fiscal 2010. Pro-forma income from continuing operations was $10.8 million, or $0.06 per share, compared to $21.8 million, or $0.12 per share, in the fourth quarter of fiscal 2010.

Read full article at : http://crwepicks.com/19283/top-news/zqk-rimm-swks-clno-srev-stock-highlights-by-crwepickscom/


THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The CRWEPicks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer (http://crwepicks.com/disclaimer ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEPicks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. ( read more at http://crwepicks.com/disclaimer ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings, Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings, Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings, Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings, Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services and 4,000,000 shares of 144 restricted stocks from the company for management fee through end of June for Cleantech Transit, Inc. (CLNO.OB).

(HOLX, CEVA, VRNT, CLNO, QLIK) Noticeable Stock by Stock-PR.com

December 16th, 2011 at 02:57 pm

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com













Hologic, Inc. (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced that the U.S. Food and Drug Administration (FDA) has approved its Cervista HTA (high throughput automation) system for use with the Company's previously approved Cervista human papillomavirus (HPV) HR test. The Company's HPV HR test utilizes Hologic's proprietary Invader technology to detect 14 high risk types of HPV that are associated with cervical cancer and precancerous lesions.

The Company's Cervista HTA system automates the DNA extraction and detection steps of the Hologic Cervista HPV HR test allowing users to walk away after loading the instrument and return the next morning to review the test results.

"Our new Cervista high throughput automation system represents a significant addition to our molecular diagnostics product portfolio," said Rob Cascella , President and Chief Executive Officer of Hologic. "The Cervista HTA system automates our Cervista HPV HR test, providing higher throughput, improved chain of custody and accurate results. We are extremely pleased to get this product approved as it materially changes the competitive landscape for Hologic."

"With over 200 U.S. laboratories currently running our Cervista HPV HR test, we have had tremendous success with the early adoption of our manual HPV test," said Rohan Hastie , Vice President and General Manager, Hologic Molecular Diagnostics. "We believe that our success is driven in large part by physician and laboratory confidence in the performance and comprehensive design of the Cervista HPV assays. Having HTA approved quite simply makes us even more competitive."

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, breast Magnetic Resonance Imaging, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia and uterine fibroids, permanent contraception, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications.

More about HOLX at www.hologic.com.



Read the full article at: http://stock-pr.com/?p=20971

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services and 4,000,000 shares of 144 restricted stocks from the company for management fee through end of June for Cleantech Transit, Inc. (CLNO.OB)

(GBLHF, ADTN, BLKB, TZOO) Notable Stock by Stock-PR.com

December 16th, 2011 at 12:34 pm

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com







Global Hunter Corp. (GBLHF)

Global Hunter Corp. (GBLHF.PK) is pleased to announce initial assay results from its previously announced surface sampling program. The results are encouraging with new gold showings as well as very positive copper oxide assays over wide-spread areas.

Read full article at: http://stock-pr.com/?p=20970



THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

(XLNX, ORCL, CRWE, ACIW) Stock in Focus by Stock-PR.com

December 16th, 2011 at 12:27 pm

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com








Xilinx, Inc. (NASDAQ:XLNX) announced that Steve Trimberger has been named an IEEE Fellow for "contributions to circuits, architectures and software technology for field-programmable gate arrays."

Read full article at: http://stock-pr.com/?p=20969



THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

(RRC, AH, CLNO, DL) Noticeable Stock by Stock-PR.com

December 15th, 2011 at 11:05 am

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com







RANGE RESOURCES CORPORATION (NYSE:RRC) announced several management promotions. In June, Range announced a CEO transition plan whereby Jeff Ventura, the Company's current President and Chief Operating Officer will assume the role of Chief Executive Officer beginning January 1, 2012.

Read full article at: http://stock-pr.com/?p=20959



THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services and 4,000,000 shares of 144 restricted stocks from the company for management fee through end of June for Cleantech Transit, Inc. (CLNO.OB)

(GBLHF, UNF, THO, NUS) Notable Stock by Stock-PR.com

December 15th, 2011 at 10:37 am

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com







Global Hunter (GBLHF.PK)

Molybdenum is used as an alloy agent in steel. All high strength steel contains from .25% to 8% molybdenum which contributes to the harden ability of the steel. It also improves the strength of steel under high temperatures and improves resistance to corrosion. Steel with molybdenum is used in architectural applications near the ocean; and in environments where road salts are used and there is heavy industrial pollution.

Read full article at: http://stock-pr.com/?p=20958



THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

(RPRX, GBLHF, CBK, CNK, QTM) Noticeable Stock by Stock-PR.com

December 13th, 2011 at 02:48 pm

Stock-PR Reporting





FREE Daily Stock Alerts From Stock-PR.com











Repros Therapeutics Inc.(R) (Nasdaq:RPRX) provided top line results for the end of dosing analysis on its Phase 2 clinical study of Androxal(R) in hypogonadal men with type 2 diabetes. Many men with secondary hypogonadism also have type 2 diabetes. A total of 108 men completed the three month dosing period and were the basis for this analysis. The study was conducted at 19 clinical sites in the US. A total of 119 men were enrolled in the study and satisfied the requirement of one visit in which efficacy measures could be assessed and are included in the intent to treat population. Outcomes for the "completer" and intent to treat populations were similar.

At baseline, mean morning testosterone levels for the three groups were; placebo (238 ng/dl), 12.5 mg Androxal (244 ng/dl) and 25 mg Androxal (246 ng/dl). There was no statistical difference between the groups in testosterone at baseline. At the end of the 3 month dosing period mean morning testosterone levels were placebo (231 ng/dl), 12.5 mg Androxal (445 ng/dl) and 25 mg Androxal (455 ng/dl). A comparison of either the 12.5 mg or 25 mg dose of Androxal to placebo showed them to be highly statistically different (p< 0.0001). There was no statistical difference between the two active arms. In previous Repros studies in men with low testosterone due to a variety of reasons, there was a dose dependent increase in testosterone levels.

Including all men that completed the 3 month dosing, there was a trend towards improved glycemic control in the men on the 25 mg dose. Men on the 25 mg dose saw a reduction of HbA1c (glycosylated hemoglobin) of 0.159% and a reduction of HOMA-IR (a measure of insulin resistance calculated by measuring fasting plasma glucose and insulin) of 2.89 units. Additionally, the change in HOMA-IR approached statistical significance (p=0.09) for men on the 25 mg dose. In the Intent-to-Treat population of men receiving 25 mg Androxal and who were younger than 65 years of age, the mean change in HbA1c was -0.385% which when compared to placebo men of the same age group (+0.145%) yielded a near statistically significant outcome, p=0.058.

To date, studies of testosterone replacement therapy in diabetic men conducted by others have shown no statistical difference comparing testosterone treatment to placebo when assessing impact on HbA1c levels after treatment. Trials completed by Repros have shown that unlike testosterone replacement therapy, Androxal stimulates normal production of the male hormone by the testes.

The drug was generally well tolerated at both doses compared to placebo. There were no drug related serious adverse events that led to discontinuation. The Company plans to hold a joint meeting with the Endocrine and Urologic Divisions of the FDA to discuss these and other findings.

Repros Therapeutics focuses on the development of oral small molecule drugs for major unmet medical needs that treat male and female reproductive disorders.

More about RPRX at www.reprosrx.com.

Read the full article at: http://stock-pr.com/?p=20937



THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

**************************************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Sign Up For Free Stock Alerts At http://stock-pr.com/signup



<< Newer EntriesOlder Entries >>